Experimental Infection of Muscovy Ducks with Highly Pathogenic Avian Influenza Virus (H5N1) Belonging to Clade 2.2
Authors:
- Olivier GuionieOGOlivier Guionie
- Cécile Guillou-CloarecCGCécile Guillou-Cloarec
- David CourtoisDCDavid Courtois
- Stéphanie BougeardSBStéphanie Bougeard
- Michel AmelotMAMichel Amelot
- Véronique JestinVJVéronique Jestin
- 1 March 2010
- journal article
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 54 (s1) , 538-547
Abstract
Highly pathogenic (HP) H5N1 avian influenza (AI) is enzootic in several countries of Asia and Africa and constitutes a major threat, at the world level, for both animal and public health. Ducks play an important role in the epidemiology of AI, including HP H5N1 AI. Although vaccination can be a useful tool to control AI, duck vaccination has not proved very efficient in the field, indicating a need to develop new vaccines and a challenge model to evaluate the protection for duck species. Although Muscovy duck is the duck species most often reared in France, the primary duck-producing country in Europe, and is also produced in Asia, it is rarely studied. Our team recently demonstrated a good cross-reactivity with hemagglutinin from clade 2.2 and inferred that this could be a good vaccine candidate for ducks. Two challenges using two French H5N1 HP strains, 1) A/mute swan/France/06299/06 (Swan/06299), clade 2.2.1, and 2) A/mute swan/France/070203/07 (Swan/070203), clade 2.2 (but different from subclade 2.2.1), were performed (each) on 20 Muscovy ducks (including five contacts) inoculated by oculo-nasal route (6 log10 median egg infectious doses per duck). Clinical signs were recorded daily, and cloacal and oropharyngeal swabs were collected throughout the assay. Autopsies were done on all dead ducks, and organs were taken for analyses. Virus was measured by quantitative reverse transcriptase-PCR based on the M gene AI virus. Ducks presented severe nervous signs in both challenges. Swan/070203 strain led to 80% morbidity (12/15 sick ducks) and 73% mortality (11/15 ducks) at 13.5 days postinfection (dpi), whereas Swan/06299 strain produced 100% mortality at 6.5 dpi. Viral RNA load was significantly lower via the cloacal route than via the oropharyngeal route in both trials, presenting a peak in the first challenge at 3.5 dpi and being more stable in the second challenge. The brain was the organ containing the highest viral RNA load in both challenges. Viral RNA load in a given organ was similar or statistically significantly higher in ducks challenged with Swan/06299 strain. Thus, the Swan/06299 strain was more virulent and could be used as a putative challenge model. Moreover, challenged ducks and contacts contained the same amounts of viral RNA load, demonstrating the rapid and efficient transmission of H5N1 HP in Muscovy ducks in our experimental conditions.Keywords
This publication has 45 references indexed in Scilit:
- Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic DucksJournal of Virology, 2008
- Wild Ducks as Long-Distance Vectors of Highly Pathogenic Avian Influenza Virus (H5N1)Emerging Infectious Diseases, 2008
- Experimental Infection of Swans and Geese with Highly Pathogenic Avian Influenza Virus (H5N1) of Asian LineageEmerging Infectious Diseases, 2008
- Age at infection affects the pathogenicity of Asian highly pathogenic avian influenza H5N1 viruses in ducksVirus Research, 2007
- Predicting the global spread of H5N1 avian influenzaProceedings of the National Academy of Sciences, 2006
- Emergence and predominance of an H5N1 influenza variant in ChinaProceedings of the National Academy of Sciences, 2006
- Susceptibility of North American Ducks and Gulls to H5N1 Highly Pathogenic Avian Influenza VirusesEmerging Infectious Diseases, 2006
- Mallards and Highly Pathogenic Avian Influenza Ancestral Viruses, Northern EuropeEmerging Infectious Diseases, 2005
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- An example of using mixed models and proc mixed for longitudinal dataJournal of Biopharmaceutical Statistics, 1997